BioPharma Services Report issue

For profit Phase 1
Founded: Toronto ON Canada (2006)

Organization Overview

First Clinical Trial
2016
NCT02900027
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

BioPharma Services, Inc | BioPharma Services USA

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertriglyceridemia (Phase 1)

Multiple Sclerosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 5
  • # of Trial APIs: 6